← Open Payments lookup

HADIYA HUSSAINI: Open Payments

NPI 1184359762 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,844 in 59 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,844

Food & beverage: $1,771Education: $74
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.14$436
AstraZeneca Pharmaceuticals LP9$281
Novartis Pharmaceuticals Corporation10$185
Takeda Pharmaceuticals U.S.A., Inc.4$124
GENZYME CORPORATION1$122
GlaxoSmithKline, LLC.1$122
Genentech USA, Inc.1$120
Lilly USA, LLC1$110
Incyte Corporation4$106
ARS Pharmaceuticals Operations, Inc.3$72

Products named: DUPIXENT, XOLAIR, CUVITRU, NUCALA, EBGLYSS, Opzelura, FASENRA, Rhapsido.

Industry payments across TX — which companies pay providers there.